ES

Carlos Javier Gonzalez Navarro


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Carlos Javier Gonzalez Navarro: Innovator in Microparticle Technology

Introduction

Carlos Javier Gonzalez Navarro is a notable inventor based in Spain. He has made significant contributions to the field of microparticle technology, particularly in the encapsulation of probiotics and other biologically active compounds. His innovative work aims to enhance the stability and efficacy of these compounds in various applications.

Latest Patents

Carlos has developed several noteworthy patents, including "Microparticles For Encapsulating Probiotics, Obtaining Said Microparticles And Uses Thereof." This invention focuses on microparticles that consist of a matrix made from casein and chitosan, which protects probiotic bacteria during processing, storage, and transit through the gastrointestinal tract, thereby extending their useful life. Another significant patent is "Zein Nanoparticles For Encapsulation Of Compounds, The Production And Uses Thereof." This invention involves nanoparticles that encapsulate both water-soluble and fat-soluble biologically active compounds, applicable in the food, pharmaceutical, cosmetic, and nanotechnology sectors.

Career Highlights

Throughout his career, Carlos has worked with several esteemed organizations, including the National Center for Food Technology and Safety, Ebro Laboratory, and the University of Navarra. His experience in these institutions has allowed him to refine his expertise in food technology and nanotechnology.

Collaborations

Carlos has collaborated with notable colleagues such as Maite Agueros Bazo and Irene Esparza Catalan. These partnerships have contributed to the advancement of his research and innovations in microparticle technology.

Conclusion

Carlos Javier Gonzalez Navarro is a pioneering inventor whose work in microparticle technology has the potential to revolutionize various industries. His innovative patents and collaborations highlight his commitment to advancing the field and improving the stability of biologically active compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…